1. Home
  2. MNSB vs CRBP Comparison

MNSB vs CRBP Comparison

Compare MNSB & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MainStreet Bancshares Inc.

MNSB

MainStreet Bancshares Inc.

HOLD

Current Price

$23.39

Market Cap

162.9M

Sector

Finance

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$8.98

Market Cap

184.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNSB
CRBP
Founded
2003
2009
Country
United States
United States
Employees
171
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.9M
184.4M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
MNSB
CRBP
Price
$23.39
$8.98
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$45.50
AVG Volume (30 Days)
45.3K
447.6K
Earning Date
04-20-2026
05-08-2026
Dividend Yield
1.68%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
$1.50
N/A
Revenue Next Year
$3.77
$116.00
P/E Ratio
$12.64
N/A
Revenue Growth
N/A
97.62
52 Week Low
$17.86
$7.12
52 Week High
$25.29
$20.56

Technical Indicators

Market Signals
Indicator
MNSB
CRBP
Relative Strength Index (RSI) 40.66 50.69
Support Level $22.00 $7.86
Resistance Level $23.23 $9.73
Average True Range (ATR) 0.62 0.45
MACD -0.11 -0.02
Stochastic Oscillator 1.88 35.51

Price Performance

Historical Comparison
MNSB
CRBP

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: